Although ACE levels increase in 75% of patients with untreated sarcoidosis, the biomarker's sensitivity is low and its specificity is insufficient, resulting in a low diagnostic utility for serum ACE values [14-17]. The gene discussed is ACE; the disease is sarcoidosis.